Sunesis Pharmaceuticals Inc

NASDAQ:SNSS  
1.51
+0.10 (+7.09%)
Earnings Announcements

Sunesis Pharmaceuticals Reports Third Quarter 2020 Financial Results And Recent Highlights

Published: 11/16/2020 23:30 GMT
Sunesis Pharmaceuticals Inc (SNSS) - Sunesis Pharmaceuticals Reports Third Quarter 2020 Financial Results and Recent Highlights.
Sunesis Pharmaceuticals Inc Qtrly Loss per Share $0.29.
Revenue is expected to be $0 Million
Adjusted EPS is expected to be -$0.28

Next Quarter Revenue Guidance is expected to be $0 Million
Next Quarter EPS Guidance is expected to be -$0.29

More details on our Analysts Page.